» Articles » PMID: 3015271

Pathophysiology of "cholinoceptor Supersensitivity" in Affective Disorders

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 1986 Jul 1
PMID 3015271
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Phenomenological and physiological variables demonstrate supersensitive changes to cholinergic challenge in affective disorder subjects. Theorists generally assume the primary defect is the postsynaptic muscarinic receptor. However, in addition to defectiveness or up-regulation of this receptor, the appearance of postsynaptic "cholinoceptor supersensitivity" can result from abnormal presynaptic mechanisms, membrane "pathology," derangement of intrasystolic mechanisms that amplify effects of receptor-agonist coupling, or aberrant cholinergic-monoaminergic interaction. This article discusses abnormalities of the postsynaptic receptor, regulation of postsynaptic receptor density, the presynaptic muscarinic receptor, and other mechanisms regulating the release of acetylcholine, membrane dynamics, and "cascade" mechanisms-specifically the phosphatidylinositol (PI) cycle, Ca2+ mobilization, and cyclic guanosine monophosphate (GMP) generation-as causes of cholinergic system "supersensitivity." It is suggested that an approach to the topic emphasizing site of abnormality will encourage greater clarity of thought in the study of the cholinergic component of the pathophysiology of affective illness.

Citing Articles

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder.

Park L, Furey M, Nugent A, Farmer C, Ellis J, Szczepanik J Int J Neuropsychopharmacol. 2018; 22(1):10-18.

PMID: 30184133 PMC: 6313153. DOI: 10.1093/ijnp/pyy051.


Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies.

Davis M, Holmes S, Pietrzak R, Esterlis I Chronic Stress (Thousand Oaks). 2018; 1.

PMID: 29862379 PMC: 5976254. DOI: 10.1177/2470547017710916.


Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex.

McClure-Begley T, Esterlis I, Stone K, Lam T, Grady S, Colangelo C eNeuro. 2016; 3(4).

PMID: 27559543 PMC: 4985585. DOI: 10.1523/ENEURO.0166-16.2016.


Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder.

Szczepanik J, Nugent A, Drevets W, Khanna A, Zarate Jr C, Furey M Psychiatry Res Neuroimaging. 2016; 254:67-73.

PMID: 27366831 PMC: 6711385. DOI: 10.1016/j.pscychresns.2016.06.005.


Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.

Furey M, Zarate Jr C J Clin Psychiatry. 2013; 74(8):850-1.

PMID: 24021505 PMC: 5014541. DOI: 10.4088/JCP.13ac08584.